Ron Bentsur
CEO, Chair at Nuvectis Pharma, Inc. (NVCT)
Purchase track record
Strong record. Based on 2 purchases with a full 90 days of price history.
84
Avg. 90-day return+27.2%
vs. S&P 500+24.5%
Beat the market100%
Paper profit on buys+$91K
Total bought / sold$279K / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 1SEC | NVCTNuvectis Pharma, Inc. | Buy | 12,5003,688,424 held (+0%) | $20.00 | $250K | +5.6% |
| Nov 6SEC | NVCTNuvectis Pharma, Inc. | Buy | 5,0003,525,924 held (+0%) | $5.72 | $29K | +269.2% |
- Buy
CEO, Chair Ron Bentsur bought $250K of NVCT at $20.00 — largest purchase by this insider in our records.
- Buy
CEO, Chair Ron Bentsur bought $29K of NVCT at $5.72 — first open-market purchase in our records.